|
|
Volumn 21, Issue 3, 2015, Pages 408-409
|
|
Patient with decompensated hepatitis C virus-related cirrhosis delisted for liver transplantation after successful sofosbuvir-based treatment
a
a
a
a
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
ALCOHOL;
PEGINTERFERON ALPHA;
RIBAVIRIN;
SOFOSBUVIR;
ANTIVIRUS AGENT;
AGED;
ASCITES;
BACTERIAL INFECTION;
CASE REPORT;
CHILD PUGH SCORE;
DECOMPENSATED LIVER CIRRHOSIS;
DRUG USE;
EDITORIAL;
END STAGE LIVER DISEASE;
FEMALE;
GENOTYPE;
HEPATIC ENCEPHALOPATHY;
HEPATITIS C;
HOSPITALIZATION;
HUMAN;
LIVER CELL CARCINOMA;
LIVER FUNCTION;
LIVER TRANSPLANTATION;
MODEL FOR END STAGE LIVER DISEASE SCORE;
PARACENTESIS;
PORTAL VEIN THROMBOSIS;
PRIORITY JOURNAL;
TREATMENT OUTCOME;
COMPLICATION;
DRUG COMBINATION;
HEPATITIS C, CHRONIC;
HOSPITAL ADMISSION;
LIVER CIRRHOSIS;
REMISSION;
TIME;
VIROLOGY;
VIRUS LOAD;
AGED;
ANTIVIRAL AGENTS;
DRUG THERAPY, COMBINATION;
FEMALE;
HEPATITIS C, CHRONIC;
HUMANS;
LIVER CIRRHOSIS;
LIVER TRANSPLANTATION;
REMISSION INDUCTION;
RIBAVIRIN;
SOFOSBUVIR;
TIME FACTORS;
TREATMENT OUTCOME;
VIRAL LOAD;
WAITING LISTS;
|
|
EID: 84923655044
PISSN: 15276465
EISSN: 15276473
Source Type: Journal
DOI: 10.1002/lt.24051 Document Type: Editorial |
|
Times cited : (29)
|
|
References (5)
|
